Prosight Management »

Ovid Therapeutics shares owned by Prosight Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 983k 3.05